FinBoss.io
CSEN
  • Crypto prices
  • Liquidation War
  • Crypto tools
  • Bitcoin on-chain
  • US macro
  • US stocks
    • Largest US stocks
    • Stock screener
    • Earnings calendar
    • Insider trading
    • Market heatmap
  • Markets
  • Tools
  • Guides
  • FinBot
FinBoss.io
Crypto prices
Liquidation War
Crypto tools
Altcoin Season Index
Big players (on-chain)
Bitcoin halving countdown
Bear market radar
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Largest US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Markets
Stock indices
Commodities
Forex rates
Bear market radar
Famous investors' portfolios
Tools
Dashboards
Investor dashboardTrader dashboardBeginner dashboard
Calculators
Compound interestDCA calculatorDrawdown recovery
Compare
BrokersCrypto exchanges
Přehled sekce Tools →
Guides
FinBot
CSEN
Home
Stocks
Healthcare Rlty Trust
HR

Healthcare Rlty Trust

HRNASDAQ

Stock · Data from SEC EDGAR 13F · Held by 9 of 87 tracked investors

$17.89
▼ 0.50%
Famous investorshold 9buying 0selling 0
Price (USD)
$17.89
Market cap
$6.2B
P/E ratio
–
Tracked investors holding
9 of 87
Next earnings
29 Oct 2026

Healthcare Rlty Trust at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
37out of 100
  • Valuation8
  • Growth53
  • Profitability39
  • Quality43
  • Debt31
  • Stability48
In its favour
  • ✓The analysts' average target is 18% above the price.
What to watch
  • !The company is loss-making: net profit is negative.
  • !Net debt is high: at the current free cash flow it would take 8.9 years to repay.
  • !It pays out more in dividends than it earns.
  • !The stock is expensive: you pay 447.3 USD for 1 USD of annual earnings.

The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

Is the stock expensive?

Expensive

The company has no earnings, so the P/E cannot be calculated.

P/E
–
P/S
5.4×
EV/EBITDA
15.1×

Is the company growing?

Growing slowly
22
23
24
25

Revenue over 3 years grew 7.8% a year. Last year -4.3%.

Does it make money?

Loss-making

Revenue and net profit (USD B)

Margins (% of revenue)

Free cash flow and capex (USD B)

Cash and debt (USD B)

Earnings per share (EPS, USD)

Latest quarters (USD B)

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 202630 Jul 20260.410.40+2.5%
Mar 202630 Apr 20260.410.39+5.1%
Dec 202512 Feb 20260.400.400%
Sep 202530 Oct 20250.410.40+2.5%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

Chart HR

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

9
JS
Jeff Smith
Starboard Value
0.86%$39,054,505▼ -71.6%
RP
Richard Pzena
Pzena Investment Management
0.13%$44,886,923unchanged
JG
Joel Greenblatt
Gotham Asset Management
0.12%$53,537,211▼ -3.9%
GI
Generali Investments CEE
Generali Investments CEE
0.09%$1,815,300unchanged
JS
Jim Simons
Renaissance Technologies
0.07%$51,660,856▲ +65.3%
IE
Israel Englander
Millennium Management
0.03%$70,209,450▲ +51.7%
CA
Cliff Asness
AQR Capital Management
0.03%$86,475,550▲ +44.6%
Ns
Norský státní fond
Norges Bank
0.01%$76,681,055New position
Šn
Švýcarská národní banka
Swiss National Bank
0.01%$13,413,050▲ +0.6%

Frequently asked questions

How much is Healthcare Rlty Trust (HR) stock?

Healthcare Rlty Trust shares trade at $17.89, -0.50% over the last trading day. The price is delayed.

What is the market cap of Healthcare Rlty Trust?

The market cap of Healthcare Rlty Trust is about $6.2B.

Which big investors hold Healthcare Rlty Trust?

According to the latest 13F filings, 9 of 87 tracked investors hold Healthcare Rlty Trust, for example Jeff Smith, Richard Pzena, Joel Greenblatt.

When will Healthcare Rlty Trust report its next results?

The next earnings report of Healthcare Rlty Trust is expected on 29 Oct 2026.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms of usePrivacy policyCookie policy

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

  • Cost of sales 39
  • Research 0.0
  • Operations and selling 52.8
  • Taxes and other 29.6
  • Net profit -21.4
  • Out of 100 USD of revenue, -21.4 USD is left as net profit.

    Is it financially healthy?

    Watch the debt
    Cash
    25M USD
    Debt
    4.4B USD
    Free CF
    493M USD

    It could repay its net debt from free cash flow in 8.9 years.

    Does it pay a dividend?

    Risky
    Yield
    5.34%
    Of earnings
    827%

    Over a year you receive roughly 5.34% of the price per share. The payout is more demanding for the company. It has raised the dividend for 2 years in a row.

    What do analysts expect?

    Buy
    Average target
    21.08 USD
    Vs price
    +18%

    12 analysts. Their opinion is not a recommendation by FinBoss.io.

    Which big investors hold it?

    9 of 87

    Among the tracked investors, Jeff Smith, Richard Pzena, Joel Greenblatt and others hold the stock according to 13F filings.

    Dividend per share by year (USD)

    * the year has not ended yet. Source: Yahoo Finance.

    Ratios

    P/E
    –
    Forward P/E
    447.3×
    P/B
    1.5×
    P/S
    5.4×
    PEG
    8.82
    EV/EBITDA
    15.1×
    Gross margin
    61.9%
    Operating margin
    14.7%
    Net margin
    -7.6%
    ROE
    -1.9%
    ROA
    0.9%
    Debt / equity
    1.0×
    Current ratio
    0.3×
    Revenue growth
    -4.3%
    Earnings growth
    –
    Beta
    0.84
    Dividend
    5.34%
    Payout ratio
    827%